Cadence Bank’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.12M Sell
3,909
-54
-1% -$15.5K 0.07% 160
2025
Q1
$1.22M Buy
3,963
+47
+1% +$14.5K 0.09% 144
2024
Q4
$1.38M Sell
3,916
-29
-0.7% -$10.2K 0.09% 138
2024
Q3
$1.41M Sell
3,945
-61
-2% -$21.9K 0.1% 142
2024
Q2
$1.28M Hold
4,006
0.1% 126
2024
Q1
$920K Buy
4,006
+26
+0.7% +$5.97K 0.07% 164
2023
Q4
$875K Hold
3,980
0.07% 170
2023
Q3
$899K Hold
3,980
0.08% 155
2023
Q2
$879K Sell
3,980
-49
-1% -$10.8K 0.08% 165
2023
Q1
$902K Sell
4,029
-60
-1% -$13.4K 0.08% 158
2022
Q4
$1.14M Sell
4,089
-25
-0.6% -$6.95K 0.11% 141
2022
Q3
$861K Hold
4,114
0.09% 153
2022
Q2
$969K Sell
4,114
-134
-3% -$31.6K 0.14% 80
2022
Q1
$762K Sell
4,248
-176
-4% -$31.6K 0.09% 105
2021
Q4
$956K Buy
4,424
+11
+0.2% +$2.38K 0.12% 98
2021
Q3
$815K Buy
4,413
+118
+3% +$21.8K 0.11% 106
2021
Q2
$770K Buy
4,295
+101
+2% +$18.1K 0.11% 108
2021
Q1
$702K Buy
4,194
+102
+2% +$17.1K 0.11% 114
2020
Q4
$621K Buy
4,092
+28
+0.7% +$4.25K 0.1% 130
2020
Q3
$410K Hold
4,064
0.08% 132
2020
Q2
$492K Buy
4,064
+7
+0.2% +$847 0.1% 127
2020
Q1
$385K Buy
4,057
+142
+4% +$13.5K 0.1% 125
2019
Q4
$345K Buy
3,915
+112
+3% +$9.87K 0.06% 157
2019
Q3
$303K Sell
3,803
-21
-0.5% -$1.67K 0.03% 185
2019
Q2
$299K Buy
3,824
+97
+3% +$7.58K 0.03% 182
2019
Q1
$437K Sell
3,727
-46
-1% -$5.39K 0.04% 157
2018
Q4
$410K Sell
3,773
-307
-8% -$33.4K 0.05% 163
2018
Q3
$522K Buy
4,080
+196
+5% +$25.1K 0.05% 155
2018
Q2
$440K Buy
3,884
+397
+11% +$45K 0.04% 164
2018
Q1
$392K Buy
3,487
+257
+8% +$28.9K 0.04% 170
2017
Q4
$478K Buy
+3,230
New +$478K 0.05% 156